findmyKOL

Joshua Sparling, MD

Basic profile

Maine-Dartmouth Family Medicine Residency

ORCIDNone on fileNPI
RegionAugusta, ME · NortheastSpecialtyDermatologyFocusDermatology
Last active 2021findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2020Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Joshua Sparling is a Dermatology physician affiliated with Maine-Dartmouth Family Medicine Residency. OpenAlex indexes 7 publications with 231 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Distinct works indexed by OpenAlex.

231citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

6 E Chestnut St
Augusta, ME 043305758

Telephone

207-623-6680

Registry record last updated 31 May 2019.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    34.6%
    Corticosteroid25%
    Triamcinolone Acetonide100%
    Part D81 patients
    Antivirals4.8%
    Imiquimod100%
    Part D14 patients

    + 2 more classes in this area

  • Anti-infectives

    25.4%
    Azole Antifungal16.2%
    Ketoconazole100%
    Part D52 patients
    Nitroimidazole Antimicrobial5.6%
    Metronidazole100%
    Part D20 patients

    + 1 more class in this area

  • Cancer & immunology

    15.4%
    TNF inhibitor5.2%
    Humira Pen100%
    Part D<11 patients
    Nucleoside Metabolic Inhibitor5%
    Fluorouracil100%
    Part D20 patients

    + 2 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

  • Multiple hyperpigmented papules and plaques.

    PubMed

    2020
  • Oral findings in 58 adults with tuberous sclerosis complex

    Journal of the American Academy of Dermatology

    2007
  • Imiquimod in the treatment of alopecia universalis.

    PubMed

    2007
  • What's eating you? Pigeon mite (Dermanyssus gallinae).

    PubMed

    2007
  • Bullous pemphigoid following therapy with an oral beta-blocker.

    PubMed

    2006
2 more publications behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”